Synendos Therapeutics AG
2 clinical trials · Sponsor
◉ Watch Synendos Therapeutics AG
| Record | Firm | Date |
|---|---|---|
| A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Disorder (NCT07478744) | Synendos Therapeutics AG | 2026-04-22 |
| A Phase 1 Single Dose and Multiple Ascending Dose Study to Assess the Relative Bioavailability, Food Effect, Safety, Tolerability and Pharmacokinetics of SYT-510 in Healthy Participants (NCT06670950) | Synendos Therapeutics AG | 2024-11-04 |
Track Synendos Therapeutics AG automatically
Every clearance here is in the API, with alerts when new ones post.